Latest Developments
03 February 2011
A5 Laboratories has received approval letter for it’s containment level 2 facility.
MONTREAL, QUEBEC–(Marketwire – 02/03/11) – A5 Laboratories Inc. (A5 Labs) (OTC.BB:AFLB – News) announced today the office of Biohazard and Containment Safety
01 February 2011
A5 Laboratories, Inc. Announces Successful Production of VI-1718 Interferon Product
MONTREAL, QUEBEC–(Marketwire – 02/01/11) – A5 Laboratories Inc. (A5 Labs) (OTC.BB:AFLB – News) announced today the successful production of its VI-1718 interferon product by its European manufacturing partner.
Pharmaceuticle Synthesis
The Synthesis Team
The Synthesis Team provides laboratory-scale drug substances reference standards and reference markers. We are currently establishing GMP-compliant synthesis operations and expect to officialize this service in the near future.
Our experienced team has a thorough understanding of pharmaceutical development and is committed to synthetic excellence.
Furthermore, A5 Lab’s premier analytical services and attention to compliance will guarantee that your synthesis will be first-rate.